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Background: Allergy to peanuts and tree nuts (TNs) is one of
the leading causes of fatal and near-fatal food-induced allergic
reactions. These allergies can be lifelong and appear to be
increasing in prevalence. Despite the seriousness of these aller-
gies, the prevalence of peanut and TN allergy in the general
population is unknown.
Objective: We sought to determine the prevalence of peanut
and TN allergy among the general population of the United
States. 
Methods: We used a nationwide, cross-sectional, random digit
dial telephone survey with a standardized questionnaire. 
Results: A total of 4374 households contacted by telephone
participated (participation rate, 67%), representing 12,032
individuals. Peanut or TN allergy was self-reported in 164
individuals (1.4%; 95% confidence interval [CI], 1.2%-1.6%)
in 151 households (3.5%; 95% CI, 2.9%-4.0%). The preva-
lence of reported allergy in adults (1.6%) was higher than that
found in children under 18 years of age (0.6%). In 131 individ-
uals, details of the reactions were obtained. When applying cri-
teria requiring reactions to be typical of IgE-mediated reac-
tions (hives, angioedema, wheezing, throat tightness, vomiting,
and diarrhea) within an hour of ingestion, 10% of these sub-
jects were excluded. Among the remaining 118 subjects, aller-
gic reactions involved 1 organ system (skin, respiratory, or gas-
trointestinal systems) in 50 subjects, 2 in 45 subjects, and all 3
in 23 subjects. Forty-five percent of these 118 respondents
reported more than 5 lifetime reactions. Only 53% of these
118 subjects ever saw a physician for the allergic reaction, and
only 7% had self-injectable epinephrine available at the time
of the interview. The prevalence of peanut and TN allergy was
adjusted by assuming that 10% of the remaining 33 subjects
without a description of their reactions would also be excluded
and correcting for a 7% false-positive rate for the survey
instrument. A final “corrected” prevalence estimate of 1.1%
(95% CI, 1.0%-1.4%) was obtained. 
Conclusions: Peanut and/or TN allergy affects approximately
1.1% of the general population, or about 3 million Americans,
representing a significant health concern. Despite the severity
of reactions, about half of the subjects never sought an evalua-
tion by a physician, and only a few had epinephrine available
for emergency use. (J Allergy Clin Immunol 1999;103:559-62.)
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There are several features of peanut (a legume) and
tree nut (TN) (eg, walnut, almond, and cashew) allergy
that have attracted recent attention in both the public
press and in biomedical research. Although food-induced
allergic reactions are the most common cause of anaphy-
laxis,1 peanuts and TNs are responsible for the majority
of severe food-induced allergic reactions.2,3 In addition,
patients allergic to peanuts and TNs rarely become toler-
ant of these foods4 and face a lifetime of avoidance. The
ubiquitous nature of these foods, combined with the
potential for cross-contamination in bakeries, restau-
rants, and processed food lines, makes avoidance diffi-
cult and accidental ingestion common.4
Despite the seriousness of the problem, there have
been no reports attempting to determine the prevalence
of peanut and TN allergy in the general population. The
only published report concerning the prevalence of
peanut and TN allergy in unselected subjects was by
Tariq et al5 who followed a birth cohort of 1218 children
on the Isle of Wight. They found a 1.2% sensitization rate
(on the basis of positive skin prick test responses) at 4
years of age, with 8 children (0.5%) having experienced
a clinical reaction. To estimate the prevalence of self-
reported peanut and TN allergy among the general popu-
lation of the United States, we conducted a random digit
dial (RDD) telephone survey of 4374 participating
households, representing 12,032 individuals. 
METHODS
Survey methods
A nationwide, cross-sectional RDD telephone survey of house-
holds in the continental United States was performed by Innovative
Medical Research, Inc (Towson, Maryland), using a questionnaire
developed with the investigators that elicited primarily “yes/no”
responses and was administered verbatim by using a computer-
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assisted system. A straight, unweighted RDD method (random sam-
pling of all telephone numbers in the continental US) was used,
with a call list generated by the Genesys Sampling System (Fort
Washington, Pa). Up to 10 attempts were made to contact each tele-
phone number. Nonresidential calls were excluded.
Questionnaire contents, eligibility, surrogate
rules, and data processing
Verbal informed consent was obtained, and subject confidential-
ity was strictly preserved. Respondents were eligible if they were
over 17 years of age, were living in the household, and understood
the questions in English. Demographic information was obtained
from all participating households. Respondents over age 17 years
provided details about allergic reactions involving minors. Adults
with TN or peanut allergy identified by a surrogate were included in
the prevalence estimate, but details of reactions in adults were only
included when the affected adult was personally interviewed. Up to
10 attempts were made to contact allergic adults identified by a sur-
rogate. For individuals who reported peanut or TN allergy, further
questions were administered to determine the details of the allergic
reactions and the history of other allergic diseases.
Reactions were considered to be “convincing” if the organ sys-
tems affected and symptoms were typical of those involved in aller-
gic reactions (skin system: hives and angioedema; respiratory sys-
tem: trouble breathing, wheezing, and throat tightness; gastroin-
testinal system: vomiting and diarrhea) and occurred within 1 hour
of ingestion. With this survey instrument and these criteria for a
convincing acute allergic reaction, only 7% of 111 pediatric sub-
jects did not have detectable serum nut-specific IgE antibodies.6
RESULTS
Participation rate
A total of 7036 households were contacted. Participa-
tion was refused by 2148 households for reasons includ-
ing immediate refusal (1267), refusal after the concept of
the survey was introduced (856), or denial of access to an
eligible household member (25). An additional 455
households were ineligible as follows: age less than 18
years (166), unable to converse in English (227), hearing
deficit or confusion (62), and incomplete interview (59).
Thus 4374 of the 7036 households participated (67%).
Household characteristics, prevalence of self-
reported peanut and TN allergy, and exclu-
sion of subjects without convincing allergic
reactions
There were a total of 12,032 individuals in the 4374
households (mean, 2.75 persons per household). There
were 1527 (35%) males answering the questions among
the 4363 in which the sex of the respondent was given.
Peanut and/or TN allergy was reported in 151 households
(3.5%; 95% confidence interval [CI], 2.9%-4.0%; no
households with >2 individuals affected). There were
164 individuals with peanut and/or TN allergy, giving a
prevalence rate of 1.4% (95% CI, 1.2%-1.6%). Table I
shows the age distribution of the participants and those
reporting peanut and TN allergy. Four adults reported
both peanut and TN allergy. There was a higher preva-
lence of allergy in adults (1.6%) than in children (0.6%;
chi-square, <0.0001, df = 17). 
Details about reactions were available for 131 of 164
(80%) individuals (16 children and 115 adults). One
child and 12 adults did not have convincing reactions.
The child had only skin erythema from peanut, and the
time from ingestion to reaction was not recalled. Among
adults without convincing reactions, 7 reporting peanut
allergy had no symptoms or unconvincing symptoms
(sinusitis, migraine, and canker sores). Three adults
reporting TN allergy had unrelated or unconvincing
symptoms (possible diarrhea, isolated dizziness, and
sores in mouth), and 2 adults reporting reactions to
coconut were not considered TN reactors. Thus 118 of
the 131 participants (90%) in whom the details of the
reaction were available met the criteria for a convincing
allergic reaction.
Corrected prevalence rate
Assumptions were made to arrive at a “corrected”
prevalence of peanut and TN allergy. Because 90% of
subjects in whom details of the reaction were available
fulfilled criteria for a convincing reaction, we assumed
that 90% of the 33 individuals (29 individuals) with
unknown reaction details also would have fulfilled the
criteria. This results in 147 allergic individuals or a
prevalence of 1.2% (95% CI, 1.0%-1.4%). Reducing the
total by another 7% to reflect the potential false-positive
rate of the survey,6 a corrected prevalence of 1.1% (95%
CI, 1.0%-1.4%) was obtained. 
Clinical characteristics
Detailed information about individuals with convinc-
ing reactions was available for 118 participants (33%
male). The number of individuals with reactions to each
food was as follows: peanut, 58; walnut, 24; cashew, 8;
Brazil nut, 8; almond, 7; pecan, 7; hazel nut, 3;
Macadamia nut, 2; and unspecified mixed nuts, 6. Four
adults reported both peanut and TN allergy, and 5 report-
ed reactions to more than 1 TN.
The symptoms evoked during the first reaction in the
118 individuals included throat tightness (56%), dyspnea
(43%), wheezing (36%), angioedema (51%), urticaria
(42%), vomiting (18%), diarrhea (14%), and loss of con-
sciousness (4%). One organ system was affected in 50
subjects (42%), 2 in 45 subjects (38%), and all 3 in 23
subjects (20%). Reactions occurred shortly after expo-
sure (mean, 5.7 minutes; median, 1.5 minutes), and all
occurred within 30 minutes. Medications were used in 36
patients (31%) on the first occurrence of a reaction and
included the following: antihistamines (25 subjects),
asthma medications (12 subjects), epinephrine (9 sub-
jects), and corticosteroids (3 subjects). Multiple reactions
were common: 55% reported 1 to 5 reactions, and 45%
Abbreviations used
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reported more than 5 lifetime reactions. Atopic diseases
were also common (51% had other food allergies, 35%
had atopic dermatitis, 34% had asthma, and 33% had
allergic rhinitis); 94% of subjects reported at least 1 of
these atopic illnesses. Although 81% reported respirato-
ry tract or multiple organ system involvement, only 62 of
the 118 (53%) were evaluated for the allergy by a physi-
cian. Fifteen of the 62 (24%) that saw a physician (90%
had respiratory or multiple system reactions) were pre-
scribed self-injectable epinephrine, and only 8 of these
15 had the epinephrine available at the time of the inter-
view.
DISCUSSION
Allergic reactions to peanuts and TNs are potentially
life-threatening and were responsible for 5 of 7 near-fatal
and 10 of 13 fatal food-induced anaphylactic reactions in
2 series.2,3 In 2 case series of anaphylaxis treated in
emergency departments, food allergy was the leading
identifiable cause.7,8 Peanut or TN reactions accounted
for 36%7 and 72%8 of these food-related episodes,
respectively. Despite the potential severity of the allergy,
the prevalence in the general population has been
unknown. In this study, by using a RDD telephone sur-
vey of households in the US, 1.4% of individuals repre-
senting 3.5% of households reported peanut or TN aller-
gy (1.6% of adults and 0.6% of children). After adjusting
for subjects who did not provide a convincing history of
an acute, allergic reaction and for a potential 7% false-
positive rate of the survey instrument,6 the corrected
prevalence among the general US population is 1.1%
(95% CI, 1.0%-1.4%).
There are a number of limitations in this study, some
in regard to telephone surveys and others concerning the
self-reported diagnosis of allergy. Telephone surveys
may be biased in several respects. Overrepresentation of
persons with a high socioeconomic status may occur
because homes without telephones (5.5% of homes
according to the 1990 US Census9) are excluded,10 and
those with multiple voice lines are slightly more likely to
be selected. Ethnic and racial biases may also occur.
Because queries about race, ethnicity, income, and mul-
tiple telephone lines were not made in this study, the
degree of such biases could not be determined. Tele-
phone survey respondents are predominantly female, and
a rate of 65% females, as found in this study, is not
unusual.11 Despite the overrepresentation of women
answering the survey, the demographic data on the
households paralleled the 1990 US Census data.9
Although it is possible that the overrepresentation of
females led to an underestimate of males with peanut and
TN allergy, previous reports on patients with anaphylax-
is have also shown a preponderance of adult females
(66%),1 with more females affected as the age at reaction
increased (25% in children and 75% in adults over 40
years of age8).
There are also limitations of the survey instrument to
identify true allergy. The “gold standard” for diagnosing
food allergy is the double-blind, placebo-controlled oral
food challenge.12 However, with a convincing history of
a severe acute allergic reaction and positive skin or blood
test results indicating specific IgE antibody, oral chal-
lenges may not be indicated. It was not practical in this
study to challenge subjects taken from the general popu-
lation. However, peanut and TN reactions are usually
acute and severe, and therefore the false-positive rate of
historical determination of allergy is generally low. In a
study using this questionnaire instrument, 7% of 111
patients with convincing histories of acute reactions to
peanuts or TNs did not have detectable peanut- or TN-
specific serum IgE antibody,6 although this previous
study was performed with children, and applicability to
adult populations is only assumed. These patients may
have false-positive results, they may have outgrown their
allergy, or they may be a minority that has reactions with
very low specific IgE antibody levels. Previous surveys
have noted a false-positive rate of 13% (with a surrogate
respondent for children using allergy skin prick tests to
peanut to indicate sensitivity) to 14% (in adults).13,14
Several studies have addressed the characteristics of
clinical reactions to peanuts and TNs, and the clinical
characteristics of the reactions in this study were similar
in terms of severity, associated atopic diseases, emer-
gency medication use, and high frequency of accidental
ingestions.2,6,14-16 However, 2 observations in this study
were novel. First, only 4 subjects (all adults) reported
allergy to both peanut and at least 1 TN. Previous studies
in patients referred for allergy evaluations reported reac-
tivity to TN in 20%17 and 34%6 of patients with peanut
allergy. One explanation for the lower number of subjects
with reactions to both peanut and TN in this study is that
the respondents proffered information on either an aller-
gy to peanut or TN without mentioning the other. This
seems unlikely because subjects were prompted about
both. Alternatively, allergy to both peanuts and TNs may
TABLE I. Age distribution of subjects with reported peanut and TN allergy
Total Allergy to TNs Allergy to Allergy to Unspecified allergy to
population and/or peanuts peanuts only TNs only peanut and/or TN
Adults 8049 131 (1.6%) 59 (0.7%) 59 (0.7%) 17 (0.2%)
Children 
(<18 y) 2998 18 (0.6%) 12 (0.4%) 5 (0.2%) 1 (0%)
Unspecified 985 15 (1.5%) — — 15 (1.5%)
Total 12,032 164 (1.4%) 71 (0.6%) 64 (0.5%) 33 (0.3%)
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not be as common in the general population compared
with the rate reported in referral populations. The second
novel finding was that these allergies were more common
in adults than in children because the general prevalence
of food allergy is generally greater in children (7%) than
in adults (1% to 2%).18 Because peanut and TN allergies
are usually not outgrown,4,19 there may be a greater rep-
resentation among adults, a population that has accumu-
lated affected individuals. The prevalence of peanut-
induced (0.4%) and TN-induced (0.2%) allergic reac-
tions among children in this study was similar to that
reported in a birth cohort of 1218 children in the Isle of
Wight evaluated at age 4 years (0.5% for peanut and
0.2% for TN).5
This study also revealed important issues about treat-
ment of these allergies. Only half of the patients consult-
ed a physician about their allergy. Also worrisome was
the fact that epinephrine was apparently underprescribed,
a finding previously reported.20,21 Despite the fact that
90% of the patients seeing a physician had reactions
involving the respiratory tract or multiple organ systems,
only 24% were prescribed epinephrine. Only 53% of
those subjects prescribed epinephrine had it available at
the time of the survey.
This telephone survey indicates that 1.4% of the gen-
eral US population report peanut/TN allergy. In applying
conservative criteria to correct for unconvincing histories
and false-positive determinations, at least 1.1% of the
general population, or about 3 million Americans, has
experienced acute allergic reactions to peanuts or TNs.
Most of these individuals experienced multiple and
severe reactions. Despite the seriousness of the allergy,
relatively few sought medical attention, and for those
who did, self-injectable epinephrine was underpre-
scribed. Implications for the identification, education,
and treatment of patients and increased research efforts
are evident.
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